T1	Participants 103 138	in children with autistic disorder.
T2	Participants 422 452	125 children (ages 2-17 years)
T3	Participants 520 570	no significant differences across treatment groups
T4	Participants 853 903	conducting rigorous trials in children with autism
T5	Participants 977 1016	symptomatic effects in this population.
